We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Silver Dressing Battles Bacterial Contamination

By HospiMedica International staff writers
Posted on 26 Sep 2013
A novel wound dressing combines a highly absorbent gelling fiber filler dressing with the benefits of silver (Ag).

The DURAFIBER Ag is a broad-spectrum antimicrobial dressing that is made of a unique nonwoven fiber blend (integral to its high performance) that provides clinicians with a different approach to address bacterial contamination posed by medium to heavily exuding wounds. More...
The conformable gel matrix helps promote patient concordance and comfort, while reducing dead space where bacteria may proliferate. Dressing efficiencies include minimal shrinkage when wet, which helps to maintain sustained coverage and a favorable moist wound healing environment.

The dressings provides sustained release of silver and antimicrobial activity for up to seven days against a broad spectrum of aerobic and anaerobic bacteria, including antibiotic resistant strains such as Methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa, VRE, Candida albicans, Bacteroides fragilis, and Rhizopus arrhizus, as well as yeasts and filamentous fungi wound pathogens for up to 7 days, killing the pathogens within 30 minutes of contact.

The dressings also provides effective exudate management by locking in fluid and harmful bacteria due to a high absorption and retention capacity, as well as minimal lateral wicking, which helps protect surrounding skin against maceration. When done, the clean one-piece dressing removal lowers risk of fiber shed and dressing residue, while causing minimal pain and trauma to the patient. The DURAFIBER Ag is a product of Smith & Nephew (London, United Kingdom), and has been approved by the US Food and Drug Administration (FDA).

“DURAFIBER Ag is strong when wet—a key attribute for ease of use for gelling fiber dressings” said Robin Carlstein, interim president of advanced wound management at Smith & Nephew. “The DURAFIBER portfolio facilitates clean, cost-effective, one-piece dressing removal continuing on the Smith & Nephew commitment to deliver consistent clinical and economic benefits for wound care.”

Related Links:

Smith & Nephew



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.